XT
CORT icon

XTX Topco’s Corcept Therapeutics CORT Stock Holding History

XTX Topco’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
25,690
+10,882
+73% +$657K 0.03% 1015
2026
Q1 		$597K Sell
14,808
-65,746
-82% -$2.46M 0.01% 1864
2025
Q4 		$2.8M Buy
+80,554
New +$6.33M 0.07% 369
2025
Q3 		– Sell
-19,858
Closed -$1.46M – 2675
2025
Q2 		$1.46M Buy
+19,858
New +$1.44M 0.06% 467
2025
Q1 		– Sell
-13,657
Closed -$688K – 2508
2024
Q4 		$688K Buy
+13,657
New +$716K 0.06% 513
2023
Q1 		– Sell
-33,889
Closed -$688K – 1331
2022
Q4 		$688K Buy
33,889
+24,369
+256% +$611K 0.15% 178
2022
Q3 		$244K Buy
+9,520
New +$255K 0.06% 642

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's CORT Position: Q2 2026 in Review

XTX Topco increased its Corcept Therapeutics (CORT) stake by 73% in Q2 2026, buying an estimated $657K and bringing the position to 25,690 shares worth $2.23M. The position accounts for 0.03% of the portfolio, ranked #1015.

XTX Topco first reported a position in CORT in Q3 2022 and has held it in 7 quarters since. The position peaked at $2.8M in Q4 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • XTX Topco held 25,690 shares of Corcept Therapeutics worth $2.23M as of Q2 2026.
  • XTX Topco bought 10,882 Corcept Therapeutics shares in Q2 2026, an estimated $657K.
  • Corcept Therapeutics made up 0.03% of XTX Topco's portfolio in Q2 2026, its #1015 holding.
  • XTX Topco first reported a position in Corcept Therapeutics in Q3 2022 and has held it in 7 quarters since.
  • XTX Topco's Corcept Therapeutics position peaked at $2.8M in Q4 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.